| Summary of Net Revenue Cost of Sales, Operating Profit, Depreciation and Amortization, Interest Expense, Income Tax Benefit (Expense), Other Comprehensive Income, and Assets by Segment |
The following table shows, by segment: net revenue, cost of sales,
operating profit, depreciation and amortization, interest expense,
income tax benefit (expense) and other comprehensive income for the
three months ended February 29, 2016:
|
|
|
|
|
|
Net revenue:
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
5,020,459 |
|
|
Prepacyte®-CB
|
|
|
131,739 |
|
|
|
|
|
|
|
Total net revenue
|
|
$ |
5,152,198 |
|
|
|
|
|
|
|
Cost of sales:
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
1,245,023 |
|
|
Prepacyte®-CB
|
|
|
103,268 |
|
|
|
|
|
|
|
Total cost of sales
|
|
$ |
1,348,291 |
|
|
|
|
|
|
|
Depreciation and amortization:
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
28,678 |
|
|
Prepacyte®-CB
|
|
|
12,870 |
|
|
|
|
|
|
|
Total depreciation and amortization
|
|
$ |
41,548 |
|
|
|
|
|
|
|
Operating income:
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
127,951 |
|
|
Prepacyte®-CB
|
|
|
28,471 |
|
|
|
|
|
|
|
Total operating income
|
|
$ |
156,422 |
|
|
|
|
|
|
|
Interest expense:
|
|
|
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
246,943 |
|
|
Prepacyte®-CB
|
|
|
14,391 |
|
|
|
|
|
|
|
Total interest expense
|
|
$ |
261,334 |
|
|
|
|
|
|
The following table shows the assets by segment as of
February 29, 2016 and November 30, 2015:
|
|
|
|
|
|
|
|
|
|
Assets:
|
|
|
Umbilical cord blood and cord tissue stem cell service
|
|
$ |
16,349,269 |
|
|
$ |
16,697,621 |
|
|
|
|
|
Prepacyte®-CB
|
|
|
2,750,889 |
|
|
|
2,800,325 |
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
19,100,158 |
|
|
$ |
19,497,946 |
|
|